A novel SCN9A mutation responsible for primary erythromelalgia and is resistant to the treatment of sodium channel blockers (Q34576217)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
A novel SCN9A mutation responsible for primary erythromelalgia and is resistant to the treatment of sodium channel blockers
scientific article

    Statements

    A novel SCN9A mutation responsible for primary erythromelalgia and is resistant to the treatment of sodium channel blockers (English)
    0 references
    0 references
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit